| HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC (NCT05029973) | Tianjin Medical University Cancer Institute and Hospital | 2021-05-10 |
| Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria (NCT04853992) | JW Pharmaceutical | 2021-05-10 |
| PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy (NCT04745949) | M.D. Anderson Cancer Center | 2021-05-10 |
| Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer (NCT04590781) | Xencor, Inc. | 2021-05-10 |
| An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer. (NCT04660812) | Arcus Biosciences, Inc. | 2021-05-10 |
| Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) (NCT04675333) | ALX Oncology Inc. | 2021-05-10 |
| Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML (NCT04588922) | Sellas Life Sciences Group | 2021-05-10 |
| Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition (NCT05022212) | University of California, San Francisco | 2021-05-10 |
| PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis (NCT04762719) | Mayo Clinic | 2021-05-10 |
| Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Mechanically Ventilated ICU Patients (NCT04790734) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-05-10 |
| Specialized Pacing for Patients With Congenital Heart Disease (NCT03361189) | University of California, Los Angeles | 2021-05-09 |
| Photopheresis in Early-stage Mycosis Fungoides (NCT05680558) | Columbia University | 2021-05-08 |
| Effectiveness of Colchicine Among Patients With COVID-19 Infection (NCT04867226) | Hawler Medical University | 2021-05-08 |
| Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections (NCT04859621) | Zensun Sci. & Tech. Co., Ltd. | 2021-05-08 |
| Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis. (NCT04888234) | Chang Gung Memorial Hospital | 2021-05-08 |
| Covid-19 Vaccination in Adolescents and Children (NCT04800133) | The University of Hong Kong | 2021-05-08 |
| Clinical Trial to "Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO) (NCT04836299) | Universidad Mayor de San Simón | 2021-05-08 |
| A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation (NCT05015361) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-07 |
| A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors (NCT04686682) | Jacobio Pharmaceuticals Co., Ltd. | 2021-05-07 |
| Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma (NCT04354961) | Fujian Cancer Hospital | 2021-05-07 |
| Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy (NCT04476901) | Joshua M Hare | 2021-05-07 |
| A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) (NCT04954326) | Institut de Recherches Internationales Servier | 2021-05-07 |
| Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery (NCT04891289) | Memorial Sloan Kettering Cancer Center | 2021-05-07 |
| A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma (NCT04834973) | QBiotics Group Limited | 2021-05-07 |
| CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea (NCT04886739) | CAGE Bio Inc. | 2021-05-07 |
| A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis (NCT04877990) | Bristol-Myers Squibb | 2021-05-07 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension (NCT04885491) | Attgeno AB | 2021-05-07 |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer (NCT04614103) | Iovance Biotherapeutics, Inc. | 2021-05-07 |
| A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD (NCT05297292) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2021-05-07 |
| SHR-1701 in Patients With Recurrent/Metastatic Scchn (NCT04650633) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-07 |
| A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis (NCT04908514) | Aldeyra Therapeutics, Inc. | 2021-05-07 |
| Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants (NCT04987463) | Katarzyna Kotulska | 2021-05-07 |
| A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors (NCT04866134) | Erasca, Inc. | 2021-05-07 |
| A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection (NCT04820686) | Assembly Biosciences | 2021-05-07 |
| GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) (NCT04590547) | GeneOne Life Science, Inc. | 2021-05-07 |
| KRT-232 and TKI Study in Chronic Myeloid Leukemia (NCT04835584) | Kartos Therapeutics, Inc. | 2021-05-07 |
| Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer (NCT04698915) | Galera Therapeutics, Inc. | 2021-05-07 |
| Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis (NCT04880187) | Axcella Health, Inc | 2021-05-07 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain (NCT04707157) | Eli Lilly and Company | 2021-05-06 |
| Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM (NCT04848506) | Cytokinetics | 2021-05-06 |
| Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine (NCT04565288) | Brown University | 2021-05-06 |
| A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo (NCT04818346) | Incyte Corporation | 2021-05-06 |
| ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study (NCT04431258) | Ability Pharmaceuticals SL | 2021-05-06 |
| Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus (NCT04680637) | Amgen | 2021-05-06 |
| CB-103 Plus NSAI In Luminal Advanced Breast Cancer (NCT04714619) | MedSIR | 2021-05-06 |
| Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni (NCT04679831) | Kenya Medical Research Institute | 2021-05-06 |
| Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020） (NCT04806243) | Nanfang Hospital, Southern Medical University | 2021-05-06 |
| CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome (NCT04893486) | Palvella Therapeutics, Inc. | 2021-05-06 |
| Treat COVID-19 Patients With Regadenoson (NCT04606069) | University of Maryland, Baltimore | 2021-05-06 |
| A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin (NCT04850040) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-05-06 |
| The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19 (NCT05552625) | Helixmith Co., Ltd. | 2021-05-06 |
| A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT) (NCT04264806) | Janssen Research & Development, LLC | 2021-05-06 |
| Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial (NCT04764942) | Mayo Clinic | 2021-05-06 |
| PanACEA Sutezolid Dose-finding and Combination Evaluation (NCT03959566) | Michael Hoelscher | 2021-05-06 |
| NPC - AXEL Study : Axitinib-Avelumab (NCT04562441) | Chinese University of Hong Kong | 2021-05-06 |
| An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma (NCT04873440) | Chinese PLA General Hospital | 2021-05-06 |
| Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders (NCT04463615) | City of Hope Medical Center | 2021-05-05 |
| Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease (NCT03870334) | NImmune Biopharma | 2021-05-05 |
| Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy (NCT04652570) | Tenet Medicines | 2021-05-05 |
| Adjunctive Linezolid for the Treatment of Tuberculous Meningitis (NCT04021121) | University of California, San Francisco | 2021-05-05 |
| Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML (NCT04913922) | Ludwig-Maximilians - University of Munich | 2021-05-05 |
| Effects of Glucagon-Like Peptide-1 Analogs on Sexuality (NCT04687514) | University Hospital, Basel, Switzerland | 2021-05-05 |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders (NCT03980769) | Fred Hutchinson Cancer Center | 2021-05-05 |
| Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) (NCT04682405) | Washington University School of Medicine | 2021-05-05 |
| Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy (NCT04385719) | Makerere University | 2021-05-05 |
| Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency (NCT04588688) | Tobias Else | 2021-05-05 |
| A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (NCT04777331) | Hoffmann-La Roche | 2021-05-05 |
| A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma (NCT04416451) | Memorial Sloan Kettering Cancer Center | 2021-05-04 |
| Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial (NCT04588285) | Helse Fonna | 2021-05-04 |
| A Study to Test if TEV-53275 is Effective in Relieving Asthma (NCT04847674) | Teva Branded Pharmaceutical Products R&D, Inc. | 2021-05-04 |
| Nimodipine in Vestibular Schwanommas (NCT04801953) | Medical University of Vienna | 2021-05-04 |
| Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study (NCT04742673) | Vanderbilt University Medical Center | 2021-05-04 |
| Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems (NCT04876430) | Hospital de Clinicas de Porto Alegre | 2021-05-04 |
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer (NCT04734730) | City of Hope Medical Center | 2021-05-04 |
| A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash (NCT04697069) | Vanda Pharmaceuticals | 2021-05-04 |
| A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3) (NCT04855721) | Aurigene Discovery Technologies Limited | 2021-05-04 |
| Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse (NCT04475731) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2021-05-04 |
| A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) (NCT04853576) | Editas Medicine, Inc. | 2021-05-04 |
| Evaluation of Common Bean Baked Snack Consumption on Blood Lipids in Overweight People With Altered Blood Lipid Levels (NCT05028699) | Centro Universitario de Ciencias de la Salud, Mexico | 2021-05-03 |
| Corneal Crosslinking for Treatment of Corneal Neovascularization (NCT04787471) | Price Vision Group | 2021-05-03 |
| Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial (NCT04320888) | National Cancer Institute (NCI) | 2021-05-03 |
| Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents (NCT04884685) | Sinovac Life Sciences Co., Ltd. | 2021-05-03 |
| Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder (NCT04818086) | Virginia Commonwealth University | 2021-05-03 |
| A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (NCT04791319) | Janssen Research & Development, LLC | 2021-05-03 |
| Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study (NCT04593823) | scPharmaceuticals, Inc. | 2021-05-03 |
| Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02) (NCT04700072) | Merck Sharp & Dohme LLC | 2021-05-03 |
| Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease (NCT04420364) | Brigham and Women's Hospital | 2021-05-03 |
| Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease (NCT04685499) | Weill Medical College of Cornell University | 2021-05-03 |
| Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian (NCT04741828) | PT Bio Farma | 2021-05-03 |
| Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection. (NCT04854928) | Pharma Holdings AS | 2021-05-03 |
| Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients (NCT03847311) | University of Arizona | 2021-05-03 |
| Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors (NCT04902872) | Cybrexa Therapeutics | 2021-05-03 |
| A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer (NCT04699630) | SCRI Development Innovations, LLC | 2021-05-03 |
| ChulaCov19 Vaccine in Healthy Adults (NCT04566276) | Chulalongkorn University | 2021-05-03 |
| Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) (NCT04595747) | National Cancer Institute (NCI) | 2021-05-03 |
| Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome (NCT04867252) | Khyber Medical University Peshawar | 2021-05-03 |
| Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia (NCT04543279) | Washington University School of Medicine | 2021-05-03 |
| Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II） (NCT05281549) | Beijing Tiantan Hospital | 2021-05-02 |
| Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer (NCT04900311) | Tianjin Medical University Cancer Institute and Hospital | 2021-05-01 |
| Diet Quality, Pecans, and Cardiometabolic Health (NCT04487808) | Penn State University | 2021-05-01 |